Produktbild: Crispr-Cas-Based Genome Editing for Treating Human Diseases

Crispr-Cas-Based Genome Editing for Treating Human Diseases Volume 210

Fr. 199.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

22.01.2025

Herausgeber

Vijai Singh

Verlag

Elsevier Science & Technology

Seitenzahl

308

Maße (L/B/H)

23.1/15.5/2 cm

Gewicht

630 g

Sprache

Englisch

ISBN

978-0-443-22420-1

Beschreibung

Portrait

Prof. Vijai Singh is currently serving as Head of the Department of Biosciences, School of Science and Dean (Research & Innovation) at Indrashil University, Rajpur, Mehsana, India. Prior to this, he held the position of Associate Professor in the same department at Indrashil University. He has also served as Assistant Professor in the Department of Biological Sciences and Biotechnology at the Institute of Advanced Research, Gandhinagar, and in the Department of Biotechnology at the Invertis University, Bareilly, India. Earlier of his career, Prof. Singh worked as a Postdoctoral Fellow in the Synthetic Biology Group at the Institute of Systems and Synthetic Biology, Paris, France and at the School of Energy & Chemical Engineering at the Ulsan National Institute of Science and Technology, Ulsan, South Korea. He earned his Ph.D. in Biotechnology in 2009 from the ICAR-National Bureau of Fish Genetic Resources, Uttar Pradesh Technical University, Lucknow, India. His doctoral research focused on the development of molecular and immunoassays for the diagnosis of Aeromonas hydrophila. Prof. Singh’s research interests lies in the design and construction of novel biosynthetic pathways for production of medically and industrially important biomolecules. His laboratory is also actively engaged in developing CRISPR-Cas systems for gene knock out, knock in, gene regulation and diagnostic. With over 15 years of research and teaching experience, his areas of expertise include synthetic biology, metabolic engineering, bioinformatics, microbiology, and industrial microbiology. He has an extensive academic record, with over 110 articles, 89 book chapters, 26 books and 3 patents to his credits. Prof. Singh has received number of prestigious awards, including the Bioclues Innovation, Research and Development Award (2023) from the BIOCLUES Society, the Vice Chancellor's Best Research Award (2023) from Indrashil University, and the Agathiyar Chemical Biology Award (2023) from the Society of Chemical and Synthetic Biology. At Indrashil University, he currently serves as chairman of the Board of Study, and is a member of the Academic Council of Indrashil University. He also holds the position of the Member Secretary of the Institutional Biosafety Committee (IBSC) at the university. Dr. Singh is actively involved in national and international scientific advisory roles.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

22.01.2025

Herausgeber

Vijai Singh

Verlag

Elsevier Science & Technology

Seitenzahl

308

Maße (L/B/H)

23.1/15.5/2 cm

Gewicht

630 g

Sprache

Englisch

ISBN

978-0-443-22420-1

EU-Ansprechpartner

Zeitfracht Medien GmbH
Ferdinand-Jühlke-Straße 7
99095 Erfurt
DE
produktsicherheit@zeitfracht.de

Herstelleradresse

Elsevier Science & Technology
London Wall 125
EC2Y 5AS London
GB
tradeorders@elsevier.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Crispr-Cas-Based Genome Editing for Treating Human Diseases
  • Preface
    Vijai Singh
    1. Current approaches in CRISPR -Cas systems for metabolic disorders
    DHRUV KUMAR
    2. Recent progress in CRISPR -Cas systems for CRISPR for retinal diseases
    Mayank Bansal
    3. Recent progress in CRISPR -Cas systems for cataract and blindness
    Suresh Ramakrishna
    4. Advances in CRISPR -Cas systems for muscular dystrophy
    Vancha Harish
    5. Recent development in CRISPR -Cas systems for cardiac disease
    Xin Wang
    6. Current approaches in CRISPR -Cas systems for diabetes
    L. Karthik
    7. Advances in CRISPR -Cas systems for liver disease
    Majid Mojarrad
    8. Advances in CRISPR -Cas systems for lung disease
    Suresh Ramakrishna
    9. Advances in CRISPR -Cas systems for kidney diseases
    Anil Bhanudas Gaikwad
    10. Current progress in CRISPR -Cas systems for rare disease
    Ajay Kumar I
    11. Advances in CRISPR -Cas systems for heredity disease
    DHRUV KUMAR
    12. Recent progress in CRISPR -Cas systems for neurological disorders
    Anand Krishna Tiwari
    13. CRISPR challenges in clinical developments
    Hossein Soltaninejad, Mohadeseh Khoshandam and Saman Hosseinkhani